ࡱ> b  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`acdefghijklmnopqrstuvwxyz{|}~Root Entry F[SO1?[SO14[SO14[SO1 [SO1 [SO1Arial1[SO1[SO1 [SO1[SO1[SO""#,##0;""\-#,##0""#,##0;[Red]""\-#,##0""#,##0.00;""\-#,##0.00#""#,##0.00;[Red]""\-#,##0.007*2_ ""* #,##0_ ;_ ""* \-#,##0_ ;_ ""* "-"_ ;_ @_ .))_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ ?,:_ ""* #,##0.00_ ;_ ""* \-#,##0.00_ ;_ ""* "-"??_ ;_ @_ 6+1_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ \$#,##0_);\(\$#,##0\)\$#,##0_);[Red]\(\$#,##0\) \$#,##0.00_);\(\$#,##0.00\)% \$#,##0.00_);[Red]\(\$#,##0.00\)"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\).)_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)72_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_)61_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)?:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)                                     P  P          a>     ff   `                8 8 8 8 "  ||D>}-}# #,##0.00}A}$ #,##0.00;_(@_) }A}% #,##0.00?;_(@_) }A}& #,##0.0023;_(@_) }-}' #,##0.00}A}) a#,##0.00;_(@_) }A}( #,##0.00;_(@_) }A}: e#,##0.00;_(@_) }}< ??v#,##0.00̙;_(@_)    }}; ???#,##0.00;_(@_) ??? ??? ??? ???}}- }#,##0.00;_(@_)    }A}1 }#,##0.00;_(@_) }}. #,##0.00;_(@_) ??? ??? ??? ???}-}0 #,##0.00}x}=#,##0.00;_(??? ??? ???}-}/ #,##0.00}U}* #,##0.00;_( }A}4 #,##0.00;_(}A} #,##0.00ef;_(}A} #,##0.00L;_(}A} #,##0.0023;_(}A}5 #,##0.00;_(}A} #,##0.00ef;_(}A} #,##0.00L;_(}A} #,##0.0023;_(}A}6 #,##0.00;_(}A} #,##0.00ef;_(}A} #,##0.00L;_(}A} #,##0.0023;_(}A}7 #,##0.00;_(}A} #,##0.00ef;_(}A} #,##0.00L;_(}A} #,##0.0023;_(}A}8 #,##0.00;_(}A} #,##0.00ef;_(}A} #,##0.00L;_(}A}  #,##0.0023;_(}A}9 #,##0.00 ;_(}A} #,##0.00ef ;_(}A} #,##0.00L ;_(}A}! #,##0.0023 ;_(!20% - :_eW[r 1O20% - :_eW[r 1 ef %!20% - :_eW[r 2O"20% - :_eW[r 2 ef %!20% - :_eW[r 3O&20% - :_eW[r 3 ef %!20% - :_eW[r 4O*20% - :_eW[r 4 ef %!20% - :_eW[r 5O.20% - :_eW[r 5 ef %!20% - :_eW[r 6O220% - :_eW[r 6  ef %!40% - :_eW[r 1O40% - :_eW[r 1 L %!40% - :_eW[r 2O#40% - :_eW[r 2 L湸 %!40% - :_eW[r 3O'40% - :_eW[r 3 L %!40% - :_eW[r 4O+40% - :_eW[r 4 L %!40% - :_eW[r 5O/40% - :_eW[r 5 L %!40% - :_eW[r 6O340% - :_eW[r 6  Lմ %!60% - :_eW[r 1O 60% - :_eW[r 1 23 %!60% - :_eW[r 2O$60% - :_eW[r 2 23ٗ %!60% - :_eW[r 3O(60% - :_eW[r 3 23֚ %!60% - :_eW[r 4O,60% - :_eW[r 4 23 %! 60% - :_eW[r 5O060% - :_eW[r 5 23 %!!60% - :_eW[r 6O460% - :_eW[r 6  23 %"~vRk #h+h I}% $h 1=h 1 I}%O %h 2=h 2 I}%? &h 3=h 3 I}%23 'h 4/h 4 I}%(]5]  %8^ĉ)}Y5}Y  a% *Gl;`GGl;` %OO+'^, '^[0] -{o{  }% .hgUSCQm"}x^ 2019165504 eg>m"}x^GrY^[eg>m90mg,"}x^0.4g1r\pQGilead Sciences Ireland UC4XJ05APS268A001010182157"}x^~^NP~HCVWVRWhKmnxʋ:NWV1bWNYvba'`NWp`0 2019163520 "}x^~^NGrNl"}x^0.4g,~^N0.1g5XJ05AFB229A001010182157NZfy Pba'`YNWp`0 2019165241 [lxNZfyGre25mg(NNZfy旡)6XJ05AXC169B002010181007 ͑~~ހVP[WVMuˆ}vl\BRPHBeAg3'`vba'`YNWp`0 2019164707͑~~ހVP[WVMuˆ}vl\mPN Yl\m1ml:10gsttpgNSuirb/g(R\) gPlQS7XL01XEA314E001010182435?egf<\"PS'`m]$vovAlK 3'`v@\Zfgbly'`^\~ހLv`0 2019165183vx?egf<\V[#WlxVBR0.15g(N?egf<\,vS_Nvx?egf<\0.16133g)224_VExcella GmbH & Co.KG8XL01XXF709E001010110171KTUf<\Ply'`~vLv`v N~lu0 2019164982KTUf<\V1rOyr1.0mg21ݔ{TĞW;So(ς]) gPlQS9XL01XXF709E001020110171 20191649845mg10Db0020181038000l\(uff^X- WSNck'Y)Ytf6Ro gPlQS\P(uvU_Sf11Db0020181038001 201514720Qr^|BR2mg12XL01BAL051B001010101606ff^XPl?\'VvU{|oir NSvZfg~vLv`02.0mg13XL01XXA316A001010179096eYb^)RP”Oeav YS'` Nv'`uS]Lv0uS{LvbSS'`yLv`0 2019165739eYb^)RGr)RnfSS0.15g56!_VAbbVie Deutschland GmbH & Co.KG14XL01XEB228A001010101445!TTf<\$PhvuVP[SSO2HER2 3'`v YSbly'`sNzLv`vN~lu0 2019163667legx!TTf<\Gr~^tY0.16g _lςR`^t;SoN gPlQS15XL01XEB228A001020101445 201916366680mg16XL01XCP138B002010181735^YsUSbPPN N`QeS/eN N/eN NǏ12*Ng1.HER23'`v@\Zfg0p'`begsNzLv`veRlu02.wQ gؚ YSΘiHER23'`egsNzLv`vRlu0 2019165391^YsUSbl\m^wcyr 14ml:0.42ggt_VRoche Diagnostics GmbH17XL01XCX242B002010181451O)RUSbP\~ǏN~|~Suv YSbl'`~xQW GYёm]$vv`0 2019165207O)RUSbl\m/O 10ml:0.1gOuir6Ro(ς]) gPlQS18Db0020181032000xxSf<\GrBRwcj`kSNovartis Europharm Limited.V19Db0020181032001 2017163086xxSf<\Gr }Gr60ݔQXVNovartis Europharm Limited20XL01XEL356A001010278672Sf<\KP-NqSbؚqSvSS'`Ӛ~~SPMF 0w'`~~ހXYu~SvӚ~~SPPV-MF bSS'`@\gXYu~SvӚ~~SPET-MF v`0XC02KXB144A001010178189lufWH32mg/GrRceGr P3-12\yrS'`bHQ)Y'`R ؚS`125mg/GrPWHORR~II~-IV~vR ؚSWHO,{1~ v`0 2019147425lufWGrhQS)R0.125g22XC02KXB144A001020178189 2019166533lufWRceGrRceGr32mg23XC02KXL363A001010178269)ReYqToPN N`QeS/eN1./gTc~'`b YS'`ba'`@hh^X'`R ؚSCTEPH b NKb/gvCTEPH NWHO FC :NII-IIIv`2.R '`R ؚSPAH NWHO FC :NII-III`vN~(uo0 2019166628)ReYqTGr[ TeY0.5mg42 _VBayer AG24XC02KXL363A001020178269 201916662925XC02KXL363A001030178269 20191666302.5mg8426XC02KXM170A001010178189lf~fW"PWHORR~II~-III~vR ؚSWHO,{1~ v`0 2019163217lf~fWGrP4g10mga'Y)RWhoSPatheon Italia S.p.A27XB01ACS270A001010178189Seg^RSň)35XN01BBL054V006010100156)RYaSVQ4P&^ruu`0 2019163570)RYaSVQ44BR14cm10cm(+Tϑ14g;+T)RYaSV0.7g) YT SNl_6RoN gPlQS36XR03ALW115L031010178453LNn~pQyrW8TeQ|BR P-N͑^ba'`;^X'`u0 2019163516 LNn~pQyrW8TeQ|BR'kPN#k62.5g(NLN),25g(N~pQyrW),308TzzVGlaxo 0perations UK Ltd37XR03ALY302L031010378672yrWe\f[MRg-Nt'` gsQp NSAIDsEQRlu3*Nguu;mR^ NMNON50%v^ΘnuNy;S^Ye02.[|~'`lueHe0y_b NSv-N͑^eWWrQ\u` cffN(uo043XL04ABA249B00203017818444XL04ABA249B002020178184 2019166604 0.4ml:40mg45XL04AAT163A001010178724Xblf^6Pʋefnxv{|ΘnsQp~ O~DMARDslu3-6*Nguu;mR^ NMNON50% v^ΘnuNy;S^Ye0 2018163135g|jxXblf^Gr\pg 5mg(NXblf^)'_VPfizer Manufacturing Deutschland GMBH46Db0020151011000+Y)RUSb{|KQCilag AG47Db0020151011001 l\(u+Y)RUSbInfliximab for Injection 201513268|BR ^tXCilag AG48XL04ABY179B001010178323PN N`QeS/eN1.ʋefnxv{|ΘnsQp~ O~DMARDslu3-6*Nguu;mR^ NMNON50%ʋefnxv:_v'` gp N+T>e\f[MRg-Nt'` gsQp NSAIDsEQRlu< 3*Nguu;mR^ NMNON50%v^ΘnuNy;S^Ye02.[|~'`lueHe0y_b NSv͑^eWWrQ\u` cffN(uo03.KQWi`u`vN~lu04.-N͑^nu'`~p`vN~lu049XN07XXY184B001010100344$\^tKQg(PeSv%`'`-N^:@'`RS-N` ^(WS\O48\eQ_YO(u /eN NǏ21)Y0 201510203l\(u$\^tKQgQR^ 0.15PNAUSMO^N)YnfuS;SoN gPlQS50XB01ADC119B001010104064͑~N~~W~nvSovMuirP%`'`_h{kSu12\eQO(u020156904^tz18mg/e NSmf_uiroN gPlQS51XB03XAL373E001010180523WlSNPba'`u_w+@v`0 2019165682WlSNV1r^tSS20mgsZSۏ(-NV);Sob/g_S gPlQS52XB03XAL373E001020180523 201916567153XA10BFA025A005010104520?aSl|TVGr 2019166524?aSl|TVGr mg]-NNSN6Ro gPlQS54XA10BJA085B002010179096~^X9PN2uS̀I{S gM|ob\ }c6RHeg NsOvBMIe"25v` !kYee1uN~SN N;Su:ggNy;S^_wQYe0 201514151~^Xl\m~vl10g(0.25mg/ml,2.4ml//e){%VBaxter Pharmaceutical Solutions LLC55XA10BJA085B002020179096 2015141525g(0.25mg/ml,1.2ml//e)XA10BKD256A001010101359RSň)57XA10BKD256A001010201359 201916663658XA10BKE079A001010180023i`RSň)59XA10BKK130A001010178537aSRSň)62XA10BJL366B002020181708 2019165316 3ml:0.3mg63XA05BAG145B002010103282 uIxUSJS(lx/lSPRpzbelO(uuIxS g6RBRv`0 2019152827uIxUSJS(lx/lSl\m100ml _T6Ro(-NV) gPlQS64XA05BAG145B002020103282 2019153761250ml65XA05BAJ212B002010206155|(lx7(lxP'`u0 2019163219 |(lx7(lxl\m`^t 200ml:20g [wm`y6Ro gPlQS66XA05BAJ212B002010106155 2019166579YB\qQ$cm67XA02BCA084B001010100453~nfbUP gffNhfvuuʋeN gyߘ;S1VbTTVv`0 2019163411l\(u~nfbUX=N[ =NsƖV=Ns6RoS68XC09DXS255A001010100100l^]f,lfW(Pba'`_RpzNYHA II-IV~ ` !kYee^ g\@RpeMNOvnc0 2018162954 l^]f,lfWGr#kY 0.1g(Nl^]f,lfW,l^]f49mg/,lfW51mg)PeRaWNovartis Singapore Pharmaceutical Manufacturing Private.Ltd.(<SNNS6Ro gPlQS>RSň)69XC09DXS255A001020100100 2019166621 50mg(Nl^]f,lfW,l^]f24mg/,lfW26mg)70Db00201810210000WbWSi`^tfWNO@[ϑ`0 2019150281YNWm|130/0.45u(l\m500mlSN9h$\eaSk;So gPlQS74XL03AAL367B002010101445kxW^ySanten Pharmaceutical Co., Ltd.(<S)Y6Ro(-NV) gPlQS>RSň)78XB05BAD252B002010101415 YylsN(C6^24);P~%{QΘi[{g fnxwQ g%{QΘivR NhQ%N͑R NhQdY `vN~(uo0mSS gR`O(ue NN/eN0 2017163073YylsNl\m(C6-24).100ml:6g(|6R'YFl):6g(-Nul Nxo):5g(|6RDjil):3g(~S|l)3eY0W)RFresenius Kabi Austria GmbH(<9h$\eaSkNS^t6Ro gPlQS>RSň)79XB05BAD252B002020101415 20171543155250ml:15g(|6R'YFl):15g(-Nul Nxo):12.5g(|6RDjil):7.5g(~S|l)80XB05BAF705B002010102001 Ye(lWx(18AA-d!-SF)%P~%{QΘi[{g fnxwQ g%{QΘiv`0mSS gR`O(ue NN/eN0 2019165720 Ye(lWxl\m(18AA-d!-SF)100ml:3.224g(;`(lWx) 5g((g|) VnSNJS)Y6Ro gPlQS81XB05BAF705B002010106932 2019165718250ml:8.06g(;`(lWx) 12.5g((g|)82XB05BAF705B002020102001 2019165719500ml:16.12g(;`(lWx) 25g((g|)83XV08CAG172B002010178307yr 2019166566yrl\mnfwmS 10ml:2.793g"_VBIPSO GmbH(< NwmZSyO oN gP#NlQS>RSň)XV08CAG172B002020178307 2019166567 15ml:4.1895g85XV08CAG172B002030178307 2019166568 20ml:5.586g86ZA04BAD0406010103014QQIn8NP>euT%`'`Tpv{u`0 2019162801n8N40mg270 lWS~vt^^koN gPlQS87ZA06CAJ0740010100189ёna| 2017163053|BR5g(vS_NnGr17.3g) ZOS f(SN)oN gPlQS88ZA06CAM0006010104336mT| 20191492638g YT )YN^6Ro gPlQS89ZA06CAS0338010105762\S gm 2019151341TBR(+TS gm)10mlwmWS-NvTuir6Ro gPlQS90ZA04CAT0312010100705upnV 20191572180.4g  NwmQ[oNN gPlQS91ZA12HAX0829010100864@_Ql\mPN~SN N;Su:gg͑u`v%`QebQe0 2019132443[t )Y%m~eoNN gPlQS92ZA12AAB0505010101007kQsT|P-NΘu-N~~{-N^h^X b` Yg`0 20191666316g ͑^NSh6RoN gPlQS93ZA12AAD0362010103357\g8N P-NΘu-N~~b` Yg`0 2019153540 \g8N(Sm)4l8N)Sm)8N5g/25|100 TgVeN^oNN gPlQS94ZA12AAQ0614010103250~V 20191225640.5g TgNoNƖVѐ]N YGSoNN gPlQS95ZA12AAN0048010109623_[VP-N͑^h^X0Q_u_~u`0 20191666190.3g  TgaoN gPlQS96ZA03BAQ0076010102729ĞyoV 2019105870oV(8N) ^yZoNƖV gPlQS97ZA09GAC0544010101463SLNvGr Pba'`pz`0 2019166635 _lς^oNN gPlQS98ZA09GAC0544010201463 201911286299ZA09GAQ0627010102816Ğ| 2019153959 Ğ|(e|)5g o6RoƖVN gPlQSZA12AAQ00610101070049N~| 2019166638<A lS-NU;So gPlQS101ZA12AAQ0061010207004 2019166637102ZA12GAX0006010104152~;`GrPSuNu_k'`_wv_~u`0 201916339112mg(N~;`-1)^t36Ro gPlQS103ZA12GAZ0555010100940l\(u9NSYZxPN~SN N;Su:ggh{kb` Yg` US!kOObgY/eN14)Y0 20191104020.13g(+T9NSYZx0.1g) )Y%m)YXRKNoN gPlQS104ZA09HAZ0413010100940 l\(uvl Y (Qr^)3PN~SN N;Su:ggQ_u_~uSQ_u@b]_R NhQII-III~v` US!kOObgY/eN14)Y0 201513144l\(uvl Y !0.65g(vS_N+T~S0.5g,NsTP[0.75gTQ1.5g)105ZC01AAS0667010102451ߘSs^ceP-NZfgߘSLv@bߘSrzh;v`0 2019166351ceBR10gvtt U'ksoN gPlQS106TX310001xxg Pg`ؚx@u020152xxgTVGrye)R 0.5g(Ng)VHamol LimitedO9e/eNhQ 107TX100001fYsUSbGPN N`QeS/eN1.HER23'`vsNzLvKb/gT` /eN NǏ12*Ng02.HER23'`vly'`sNzLv03.HER23'`vZfgly'`ÀLv020152660l\(ufYsUSbk[@l 0.44g(20ml)MnZVGenentech Inc.108TZ040001l\(uĞY|PN~SN N;Su:gg$v` US!kOObgY/eN14)Y020157709250mg )Y%m[6Ro gPlQS109TX120001<\YsUSb#PN>euTTluhvuVP[SSO(EGFR)h3'`vb!/c!g;TLv020157868<\YsUSbl\ml#ku 10ml:50mg ~vluiroN gPlQS110TX050001͑~N)R0PN~SN N;Su:gg(uNĉluHeg NsOv%`'`1YNP'`_Rpzwglu US!kOOb/eN NǏ3)Y020158770 l\(u͑~N)Re;m } 0.5mg(500U)? bꏷ^uir6Ro gPlQS111TX190001 ͑~N@{Qvb6R } PZfg^\~ހLv`0 201511087 ͑~N@{Qvb6R }l\mi`^3ml:15mg(24NU) q\NHQXuir6Ro gPlQS112TX090001ll^US gmSOBRXPN N`QeS/eN1.2y iTr^~ހS[SOhV[y i Sv`'`$v` g͑^|~ހ:ONvO'`f ̃T_t̃ag02. Of^Ubl^Ul'`ST_s̃u03.cT̃~{|ag0 201615478 ll^US gm`myޘS gm`BR 105ml:4.2g!Rb'YPatheon Inc.,Whitby Operations113TX270002^W@lnʑGr 2015147545 vx^W@lnʑGr25mgRb'YGLAXOSMITHKLINE INC.114TX270001 201514754612.5mg115TX260001Ukxs^ʑcʑBRW 2015158209 [lxUkxs^ʑGrʑGr VAstraZeneca Pharmaceuticals LP116TX260002 20151582140.2g117TX260003 2015158216118TX110001OsUSbPZfgly'`~vLvbZfg^ޜ^\~ހLv0 2015244529OsUSbl\m[~@l4ml:0.1g119TX140001Smf<\PEGFRWVOeazSvZfg^\~ހLv0 2016101844vxSmf<\GryrWQa'Y)RRoche S.p.A.120TZ050001SNVPSS'`Lv0LvSug TekO(u0 2016102357  TgNl6RoN gPlQS121TX140002 2016121218a'Y)RDelpharm Milano S. r.l122TX150001"}b^<\CPN N`QeS/eN1. NKb/gv~ހLv02. NKb/gb܏Ylyv~ހLv03.>e\'`xlueHev@\ YSbly'`0RSW2urzLv0 2016127506 2uxx"}b^<\GrY T_VBayer Pharma AG123TX010001)Rb2PN2uS̀I{S gM|ob\ }c6RHeg NsOvBMIe"25v` v^N~SN N;Su:ggNy;S^Ye0 2016129963)Rbl\mTR3ml:18mg9NT_lQSNovo Nordisk A/S124TZ020001OgQol\m 20161358502ml(+T{|Qo10mg) b~vՈ6RoN gPlQS125TZ030001 YeĞ۞GrPRlv%`'`e|^|~ހ}v@u0 20161432440.27g126TX290000sUSbP50\N Nn'`t^vsQ'`ĞeS'`` v^&{TN NagN1. N~~T;Sb5BUvHQ)Y'`@Su`020_'`@Su`030HQ)Y'`FVII:ONu`040wQ gGPIIb-IIIaT/bHLAbSOTe_bs(W[@\gleHeb NsOv@\geRu`0 2017163368 l\(u͑~NQ@VP[f!avQ 50KIU(1.0mg)145 A02190000NQ@VP[g! ;SOS02019046S146 A02280000NQ@vS YTir(PKb/g'YQ@Tu[vQ@YNB W@Sub4O gQ@VP[g!b6Rirv@Su`{, ,v9--6..Es//0z}122:M3444wF55 6 B7 E8 9 ~9 : +;<G==>>>]C??NT@@lA+BCCH:DE FGxG 5HIwJP_K^MNN":OO'1PVQQ`R(SnT9UUV _V V? zW ;X Y Z ZA[]&^`|` bcdteffgtgghqhi~ijj > > > > > > > >  >  >  >  >  > > > > > > > > @ ? @ ? ? ? ? ? ?  ?  ?  ?!  ?"  A# ?$ ?% ?& ?' @( ?( @( @ ?) @ ?* ? ? ?+ ?, ?-  ?.  ?  ?/  ?0  A1 ?2 ?3 ?& ?' @( ?( @( @4 ?5 @ ?6 ? ? ?+ ?7 ?8  ?9  ?  ?:  ?"  A1 ?$ ?; ?& ?' @( ?( @( @< ?= @ ?> ? ? ?? ?@ ?A  ?B  ?  ?C  ?"  A1 ?$ ?; ?& ?' @( ?( @( @D ?E @ ?F ? ? ?G ?H ?I  ?J  ?  ?K  ?"  A# ?$ ?% ?& ?' @( ?( @( @L ?M @ ?N ? ?O ?P ?Q ?R  ?S  ?T  ?U  ?"  A ?V ?W ?& ?' @( ?( @( @X ?Y @ ?Z ? ? ?[ ?\ ?]  ?^  ?_  ?`  ?0  Aa ?2 ?b ?& ?' @( ?( @( @c ?d @ ?e ? ? ?f ?g ?h ?i ?_ ?j ?0 Ak ?l ?m ?& ?' @( ?( @( @n ?o @ ?e ? ? ?f ?p ?h ?i ?_ ?q ?0 AX ?l ?m ?& ?' @( ?( @( @r ?s @4 ?t ? ?O ? ? ? ?u ? ? ? A ? ?v ?w ?x @( ?( @( @y ?z @4 ?t ? ?O ? ?{ ?t ?J ?| ?} ?" A ?V ?v ?w ?x @( ?( @( @~ ? @ ? ? ?O ? ?{ ?t ?J ?| ? ?" A ?V ?v ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ?2 ? ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?"  A1 ?$ ? ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?"  A ?$ ? ?& ?' @( ?( @( @ ? @ ? ? ?O ? ? ?  ?  ?T  ?  ?"  A ? ? ?& ?' @( ?( @( @ ? @ ? ? ?O ? ? ?  ?  ?T  ?  ?"  A ?V ? ?& ?' @( ?( @( @ ? @4 ? ? ? ? ? ?  ?  ?  ?  ?  A ? ? ?w ?x @( ?( @( @ ? @4 ? ? ? ? ? ?  ?  ?  ?q  ?0  A ? ? ?w ?x @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?q  ?0  A ? ? ?& ?' @( ?( @( @k ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ?% ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ?% ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ? ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?j  ?0  A ? ? ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ? ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A# ? ? ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ?b ?& ?' @( ?( @( @1 ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ?b ?& ?' @( ?( @( @ ? @ ? ? ? ? ? ?  ?  ?  ?  ?0  A ? ?b ?& ?' @( ?( @( @# ? @ ? ? ? ? ? ?  ?  ?_  ?  ?0  A ? ? ?& ?' @( ?( @(DZ&l@&&&&&&&&&&&&&&&&&&&&&&&&&&&&&& @!@"@#@$@%@&@'` @(@)@*@+@,@-@.@/@0@1p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w (?x (@( (?( (@( )@M )?N )@4 )?J )? )?O )? )?O )?P ) ?K ) ?T ) ?Q ) ?0 ) A )?R )?S )?w )?x )@( )?( )@( *@T *?U *@4 *?J *? *?O *? *?V *?P * ?K * ?T * ?Q * ?0 * A *?W *?S *?w *?x *@( *?( *@( +@ +?X +@ +?J +? +?O +?Y +?O +?P + ?K + ?T + ?Q + ?0 + A +?R +?S +?& +?' +@( +?( +@( ,@Z ,?[ ,@ ,?J ,? ,?O ,?Y ,?V ,?P , ?K , ?T , ?Q , ?0 , A ,?W ,?S ,?& ,?' ,@( ,?( ,@( -@\ -?] -@ -?J -? -?O -?Y -?^ -?P - ?K - ?T - ?_ - ?0 - A -?R -?S -?& -?' -@( -?( -@( .@` .?a .@ .?b .? .? .?c .?d .?e . ?f . ? . ?g . ?" . A1 .?$ .?h .?& .?' .@( .?( .@( /@i /?j /@4 /?k /? /?O /? /? /? / ?l / ? / ? / ? / A /? /?m /?w /?x /@( /?( /@( 0@n 0?o 0@4 0?p 0?q 0?O 0? 0?r 0?p 0 ?l 0 ?s 0 ? 0 ?" 0 A 0?V 0?t 0?w 0?x 0@( 0?( 0@( 1@u 1?v 1@ 1?k 1? 1?O 1?w 1?r 1?p 1 ?l 1 ?s 1 ? 1 ?" 1 A 1?V 1?t 1?& 1?' 1@( 1?( 1@( 2@x 2?y 2@ 2?z 2? 2?O 2?{ 2?| 2?} 2 ?~ 2 ?| 2 ? 2 ?" 2 A 2?V 2? 2?& 2?' 2@( 2?( 2@( 3@ 3? 3@ 3? 3? 3?O 3? 3? 3? 3 ? 3 ?| 3 ? 3 ? 3 A 3?V 3? 3?& 3?' 3@( 3?( 3@( 4@ 4? 4@ 4? 4? 4? 4? 4? 4? 4 ? 4 ?_ 4 ? 4 ?0 4 A4 4?2 4? 4?& 4?' 4@( 4?( 4@( 5@ 5? 5@ 5? 5? 5? 5? 5? 5? 5 ? 5 ?_ 5 ? 5 ?0 5 A4 5?2 5? 5?& 5?' 5@( 5?( 5@( 6@ 6? 6@ 6? 6? 6? 6? 6? 6? 6 ?J 6 ? 6 ? 6 ?0 6 A# 6? 6? 6?& 6?' 6@( 6?( 6@( 7@ 7? 7@ 7? 7? 7?O 7? 7? 7? 7 ? 7 ?T 7 ? 7 ? 7 A 7? 7? 7?& 7?' 7@( 7?( 7@( 8@ 8? 8@ 8? 8? 8?O 8? 8? 8? 8 ? 8 ?T 8 ? 8 ? 8 A 8? 8? 8?& 8?' 8@( 8?( 8@( 9@ 9? 9@ 9? 9? 9? 9?  9? 9? 9 ? 9 ? 9 ? 9 ?0 9 A 9? 9? 9?& 9?' 9@( 9?( 9@( :@ :? :@ :? :? :? :?  :? :? : ? : ? : ? : ?0 : A# :? :? :?& :?' :@( :?( :@( ;@ ;? ;@ ;? ;? ;? ;?  ;? ;? ; ? ; ? ; ? ; ?0 ; Ar ;? ;? ;?& ;?' ;@( ;?( ;@( <@ <? <@ <? <? <? <?  <? <? < ? < ? < ? < ?0 < Ar <?l <? <?& <?' <@( <?( <@( =@ =? =@ =? =? =? =?  =? =? = ? = ? = ? = ?0 = Ar =?l =? =?& =?' =@( =?( =@( >@ >? >@ >? >? >?O >? >? >? > ? > ?T > ? > ? > A >? >? >?& >?' >@( >?( >@( ?@ ?? ?@ ?? ?? ??O ?? ?? ?? ? ? ? ?T ? ? ? ? ? A ?? ?? ??& ??' ?@( ??( ?@(D@'l&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&@@A@B@C@D@E@F@G@H@I@J@K@L@@M@N@O@Pp@Q@R@S@T@U@V@W@X@Y@Z@[@\@]@^@_@ @@ @? @@ @? @? @?O @? @? @? @ ?J @ ?T @ ? @ ?" @ A @?V @? @?& @?' @@( @?( @@( A@ A? A@ A? A? A?O A? A? A? A ?J A ?T A ? A ?" A A A?V A? A?& A?' A@( A?( A@( B@ B? B@ B? B? B?O B? B? B? B ? B ?T B ? B ?" B A B?V B? B?& B?' B@( B?( B@( C@ C? C@ C? C? C?O C? C? C? C ? C ?T C ? C ?( C A C? C? C?& C?' C@( C?( C@( D@ D? D@ D? D? D?O D? D? D? D ? D ?| D ? D ?" D A D?V D? D?& D?' D@( D?( D@( E@ E? E@ E? E? E? E? E? E? E ? E ? E ? E ?0 E A E?4 E? E?& E?' E@( E?( E@( F@ F? F@ F? F? F? F? F? F? F ? F ? F ? F ?0 F A1 F?4 F? F?& F?' F@( F?( F@( G@ G? G@4 G? G? G? G? G? G? G ? G ? G ? G ? G A G? G? G?w G?x G@( G?( G@( H@ H? H@4 H? H? H? H? H? H? H ? H ? H ? H ?0 H A1 H?4 H?? H?w H?x H@( H?( H@( I@  I?  I@ I? I? I? I? I? I? I ? I ? I ? I ?0 I A1 I?4 I?? I?& I?' I@( I?( I@( J@  J?  J@ J?  J? J?O J? J? J? J ?J J ?T J ? J ?( J A J? J? J?& J?' J@( J?( J@( K@ K? K@ K? K? K?O K? K? K? K ? K ?T K ? K ? K A K?W K? K?& K?' K@( K?( K@( L@ L? L@ L? L? L? L? L?  L?! L ?" L ?T L ?# L ?0 L A L?$ L?S L?& L?' L@( L?( L@( M@% M?& M@ M?' M? M?( M?) M?* M?+ M ?, M ?- M ?. M ? M A M?l M?/ M?& M?' M@( M?( M@( N@0 N?1 N@ N?2 N? N?3 N? N?4 N?5 N ?6 N ?3 N ?7 N ?0 N A N?8 N?9 N?& N?' N@( N?( N@( O@: O?; O@ O?< O? O?O O?= O?> O?? O ?J O ?T O ?@ O ?" O A O?V O?A O?& O?' O@( O?( O@( P@B P?C P@ P?< P? P?O P?= P?D P?? P ?J P ?T P ?E P ?" P A P?V P?A P?& P?' P@( P?( P@( Q@F Q?G Q@ Q?H Q? Q?O Q?I Q?J Q?K Q ?J Q ?T Q ?L Q ?" Q A Q?V Q?M Q?& Q?' Q@( Q?( Q@( R@N R?O R@ R?H R? R?O R?I R?P R?K R ?J R ?T R ?Q R ?" R A R?V R?M R?& R?' R@( R?( R@( S@R S?S S@ S?H S? S?O S?I S?T S?K S ?J S ?T S ?U S ?" S A S?V S?M S?& S?' S@( S?( S@( T@V T?W T@ T?X T? T?O T? T?Y T?Z T ?[ T ?T T ?\ T ?" T A T?V T?] T?& T?' T@( T?( T@( U@ U?^ U@ U?X U? U?O U? U?_ U?Z U ?[ U ?T U ?` U ?" U A U?V U?] U?& U?' U@( U?( U@( V@a V?b V@ V?X V? V?O V? V?c V?Z V ?[ V ?T V ?d V ?" V A V?V V?] V?& V?' V@( V?( V@( W@e W?f W@ W?g W? W? W?h W?i W?g W ?J W ?j W ?k W ?" W Al W?$ W?m W?& W?' W@( W?( W@( X@n X?o X@ X?p X? X? X? X?q X?p X ?J X ?r X ?s X ?0 X AL X? X?t X?& X?' X@( X?( X@( Y@u Y?v Y@ Y?w Y? Y? Y? Y?x Y?w Y ?J Y ?r Y ?y Y ?0 Y AL Y?z Y?{ Y?& Y?' Y@( Y?( Y@( Z@| Z?} Z@ Z?~ Z? Z? Z? Z? Z?~ Z ?J Z ? Z ? Z ?0 Z AL Z?V Z? Z?& Z?' Z@( Z?( Z@( [@ [? [@ [? [? [? [? [? [? [ ?J [ ?_ [ ? [ ?0 [ A [?2 [? [?& [?' [@( [?( [@( \@ \? \@ \? \? \? \? \? \? \ ?J \ ?T \ ? \ ? \ A \? \? \?& \?' \@( \?( \@( ]@ ]? ]@ ]? ]? ]? ]? ]? ]? ] ?J ] ?r ] ? ] ?0 ] A ]?z ]? ]?& ]?' ]@( ]?( ]@( ^@ ^? ^@ ^? ^? ^? ^? ^? ^? ^ ?J ^ ? ^ ? ^ ?0 ^ A ^?l ^? ^?& ^?' ^@( ^?( ^@( _@ _? _@ _? _? _? _? _? _? _ ?J _ ?_ _ ? _ ?0 _ A+ _? _? _?& _?' _@( _?( _@(D@'l&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&`@a@b@c@d@e@f@g@h@i@j@k@l@m@n@o@p@q@ @r@s@t@u@v@w@x@y@z@{p@|@}@~@@ `@ `? `@ `? `? `? `? `? `? ` ?J ` ?_ ` ? ` ?0 ` A+ `? `? `?& `?' `@( `?( `@( a@ a? a@ a? a? a? a? a? a? a ?J a ? a ? a ?0 a A a? a? a?& a?' a@( a?( a@( b@ b? b@ b? b? b? b? b? b? b ?J b ? b ? b ?" b A+ b?$ b? b?& b?' b@( b?( b@( c@ c? c@ c? c? c? c? c? c? c ?J c ? c ? c ?" c A c?$ c? c?& c?' c@( c?( c@( d@ d? d@ d? d? d? d? d? d? d ?J d ?r d ? d ?0 d Ac d?z d? d?& d?' d@( d?( d@( e@ e? e@ e? e? e? e? e? e? e ?J e ?r e ?y e ?0 e A e?z e? e?& e?' e@( e?( e@( f@ f? f@ f? f? f? f? f? f? f ?J f ?r f ?y f ?0 f AL f?z f? f?& f?' f@( f?( f@( g@ g? g@ g? g? g? g? g? g? g ?J g ? g ? g ?0 g A g?l g? g?& g?' g@( g?( g@( h@ h? h@ h? h? h? h? h? h? h ?J h ?| h ? h ? h A h?V h? h?& h?' h@( h?( h@( i@ i? i@ i? i? i? i? i? i? i ?J i ?| i ? i ?" i A i?V i? i?& i?' i@( i?( i@( j@ j? j@ j? j? j? j? j? j? j ?J j ? j ? j ?0 j A j? j? j?& j?' j@( j?( j@( k@ k? k@ k? k? k? k? k? k? k ? k ? k ? k ?" k A k?$ k? k? k?' k@( k?( k@( l@ l? l@ l? l? l?O l? l? l? l ? l ?| l ? l ?0 l A l? l? l? l?' l@( l?( l@( m@ m? m@ m? m? m? m? m? m? m ?J m ?s m ? m ?" m A m? m? m? m?' m@( m?( m@( n@ n? n@ n? n? n?O n? n? n?  n ?  n ?T n ?  n ?" n A n?V n?  n? n?' n@( n?( n@( o@  o? o@ o? o? o?O o? o? o? o ? o ?| o ? o ?" o A o?V o? o? o?' o@( o?( o@( p@ p? p@ p? p? p?O p? p? p? p ? p ?T p ? p ?0 p A p?W p? p? p?' p@( p?( p@( q@ q?  q@ q?! q? q?" q?# q?$ q?% q ?& q ?' q ?( q ?" q A q?V q?) q? q?' q@( q?( q@( r@* r?+ r@ r?, r? r?- r? r?. r?/ r ?J r ?- r ?0 r ?0 r Ar r? r?1 r? r?' r@( r?( r@( s@2 s?3 s@ s?, s? s?- s? s?4 s?/ s ?J s ?- s ?5 s ?0 s Ar s? s?1 s? s?' s@( s?( s@( t@6 t?7 t@ t?8 t? t?9 t? t?: t?; t ?J t ?< t ? t ?0 t A t?4 t?= t? t?' t@( t?( t@( u@> u?? u@ u?8 u? u?9 u? u?@ u?; u ?J u ?< u ?A u ?0 u A u?4 u?= u? u?' u@( u?( u@( v@B v?C v@ v?8 v? v?9 v? v?D v?; v ?J v ?< v ? v ?0 v A v?4 v?= v? v?' v@( v?( v@( w@E w?F w@ w?G w? w?O w?H w?I w?J w ?K w ?T w ?L w ?" w A w? w? w? w?' w@( w?( w@( x@M x?N x@ x?O x? x? x?P x?Q x?R x ?S x ? x ? x ?0 x AX x?4 x?T x? x?' x@( x?( x@( y@U y?V y@ y?W y? y? y?X y?Y y?W y ?J y ?_ y ? y ?0 y A y? y?Z y? y?' y@( y?( y@( z@[ z?\ z@ z?O z? z? z?P z?] z?R z ?S z ? z ? z ?0 z A# z?4 z?^ z? z?' z@( z?( z@( {@_ {?` {@ {?a {? {? {?b {?c {?d { ?e { ? { ?A { ?0 { A {?2 {?f {? {?' {@( {?( {@( |@g |?h |@ |?i |? |?O |?j |?k |?l | ?m | ?T | ?n | ?0 | A |?W |?o |? |?' |@( |?( |@( }@p }?q }@ }?r }? }? }? }?s }?r } ?J } ?T } ?t } ? } A }? }?u }? }?' }@( }?( }@( ~@v ~?w ~@ ~?x ~? ~? ~?y ~?z ~?x ~ ?J ~ ? ~ ?{ ~ ?" ~ A ~?$ ~?{ ~? ~?' ~@( ~?( ~@( @| ?} @ ?~ ? ?O ? ? ?  ?  ?  ?  ?  A ? ? ?w ?x @( ?( @(D@'l&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&@@ @ @@@@@@@@@@@@@@ @@@ @ ? @ ?~ ? ?O ? ? ? ? ?T ? ?0 A ? ?? ?w ?x @( ?( @( @ ? @ ?~ ? ?O ? ? ? ? ?T ? ?0 A ?W ?S ?w ?x @( ?( @( @ ? @ ?~ ? ?O ? ? ? ? ?T ? ?0 A ? ?? ?& ?' @( ?( @( @ ? @ ?~ ? ?O ? ? ? ? ?T ? ?0 A ?W ?S ?& ?' @( ?( @( @ ? @ ? ? ?O ? ? ? ? ?| ? ? A ?V ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ?J ?T ? ? A ? ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ?q ?0 A# ? ?? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ? ?0 AX ?l ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ? ?0 A ?l ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ?T ? ? A ?V ? ? ?' @( ?( @( @ ? @ ? ? ?O ?  ? ? ? ?T ? ?" A ?V ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ? ?" A# ?$ ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ?  ?0 Ar ?2 ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ? ?0 A ?l ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ?q ?0 A ? ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ? ?0 Ar ?l ? ? ?' @( ?( @( @ ? @ ? ? ? ? ? ? ? ? ? ?0 A# ? ?? ? ?' @( ?( @( @ ? @ ? ? ?O ? ? ? ? ?| ? ?0 A ?W ?o ? ?' @( ?( @( @ ? @ ? ? ?O ? ? ? ? ? ? ? A ? ? ?& ? @( ?( @( @ ? @ ? ? ?O ? ? ? ? ? ? ? A ? ? ?& ? @( ?( @(,|&&&&&&&&&&&&&&&&&&&>@CB 7ggD Oh+'08@X d p|AdministratorPC@NQ8@R8՜.+,0HP X`hp x  㽭ʡҽҩƷ  F#Microsoft Office Excel 2003 CompObjoBiff8Excel.Sheet.89q